retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism peptide Retatrutide: How the Triple Agonist
Description
September 2025: Pfizer announced its agreement to acquire Metsera in a deal valued at up to USD 7.3 billion, strengthening its pipeline of next-generation GLP-1, amylin, and obesity therapies
Surgery is not right for everyone
doi: 10.1055/s-0029-1211301
However, the hormone proved disappointing in initial trials
Louis J
Shima Hadidchi, MD , is committed to providing the latest, evidence-based treatments for weight management
